Description

Canada’s health care system is complex and involves the participation of multiple stakeholders, who all have distinct roles in the planning and delivery of healthcare services. Health Canada’s decision-making role in approving a drug for marketing is distinct from the roles of those who make decisions about price-setting and public drug plan reimbursements.

Resources

Name	Format	Description	Link
Canada’s regulatory approach to drugs for rare diseases: our role in bringing drugs to patients	HTML		https://www.canada.ca/en/health-canada/services/licences-authorizations-registrations-drug-health-products/regulatory-approach-drugs-rare-diseases/our-role.html
Canada’s regulatory approach to drugs for rare diseases: our role in bringing drugs to patients	HTML		https://www.canada.ca/fr/sante-canada/services/licences-autorisation-et-enregistrement-medicaments-et-produits-sante/approche-canada-reglementation-medicaments-maladies-rares/notre-role.html

Tags

Topics

Categories